TAMs‐released CCL22 activates intratumoral CCR4/FAK/AKT axis, which induces the phosphorylation of Gli1 Ser112/Thr115/Ser116 sites, and stimulates Gli1 activity to induce the stemness and metastasis of tumor cells. This evidence concerns the gene AKT1 and neoplasm.